Document is current
Any future updates will be listed below
-
Authors
Fan, Kevin Yijun
Jerzak, Katarzyna Joanna
Kumar, Sudhir
Moravan, Veronika
Id Said, Badr
Das, Sunit
Louie, Alexander V.
Soliman, Hany
Sahgal, Arjun
Chen, Hanbo
- License Information
-
More Information
Article History
Received: 2 August 2024
Accepted: 17 September 2024
First Online: 4 October 2024
Declarations
:
: Ethics approval was obtained from the Sunnybrook Research Institute (REB SUN-5942). This study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: KJJ serves as a consultant and advisory board member for: Amgen, Astra-Zeneca, Apo Biologix, Eli Lilly, Esai, Genomic Health, Gilead Sciences, Knight Therapeutics, Merck, Myriad Genetics Inc, Pfizer, Roche, Seagen, Novartis, and Viatris. HC has received speaker’s honoraria from Novartis. These organizations had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results. No competing interests from other authors of this manuscript.
